OncoSil Medical Limited (ASX:OSL)
0.4350
0.00 (0.00%)
Jun 3, 2026, 2:22 PM AEST
OncoSil Medical Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 2.85 | 5.11 | 4.5 | 9.39 | 11.28 | 12.24 |
Cash & Short-Term Investments | 2.85 | 5.11 | 4.5 | 9.39 | 11.28 | 12.24 |
Cash Growth | -66.28% | 13.51% | -52.08% | -16.72% | -7.84% | -41.71% |
Accounts Receivable | 0.51 | 0.84 | 0.31 | 1.16 | 0.85 | 1.11 |
Other Receivables | 2.75 | 0.36 | 1.12 | 0.12 | 0.06 | 0.08 |
Receivables | 3.27 | 1.2 | 1.44 | 1.29 | 0.91 | 1.18 |
Prepaid Expenses | 0.62 | 0.41 | 0.39 | 0.44 | 0.47 | 0.11 |
Other Current Assets | - | - | - | 0.12 | 0.09 | 0.09 |
Total Current Assets | 6.74 | 6.72 | 6.33 | 11.23 | 12.74 | 13.62 |
Property, Plant & Equipment | 0.39 | 0.42 | 0.39 | 0.24 | 0.32 | 0.53 |
Total Assets | 7.13 | 7.15 | 6.72 | 11.47 | 13.07 | 14.15 |
Accounts Payable | 1.48 | 1.92 | 1.12 | 0.96 | 0.93 | 1.23 |
Accrued Expenses | 0.3 | 0.43 | 0.34 | 0.16 | 0.34 | 0.51 |
Current Portion of Leases | 0.04 | 0.05 | 0.03 | 0.15 | 0.17 | 0.16 |
Other Current Liabilities | 1.46 | 1.63 | 0.45 | 0.3 | 0.33 | 0.23 |
Total Current Liabilities | 3.29 | 4.03 | 1.94 | 1.57 | 1.77 | 2.13 |
Long-Term Leases | - | 0.02 | 0.04 | 0.02 | 0.14 | 0.32 |
Total Liabilities | 3.29 | 4.04 | 1.98 | 1.59 | 1.91 | 2.45 |
Common Stock | 99.25 | 96.43 | 90.09 | 86.51 | 79.91 | 70.4 |
Retained Earnings | -110.99 | -107.46 | -92.78 | -84.37 | -73.02 | -62.3 |
Comprehensive Income & Other | 15.57 | 14.14 | 7.42 | 7.74 | 4.28 | 3.6 |
Shareholders' Equity | 3.84 | 3.1 | 4.74 | 9.88 | 11.16 | 11.7 |
Total Liabilities & Equity | 7.13 | 7.15 | 6.72 | 11.47 | 13.07 | 14.15 |
Total Debt | 0.04 | 0.07 | 0.07 | 0.17 | 0.3 | 0.48 |
Net Cash (Debt) | 2.81 | 5.04 | 4.43 | 9.22 | 10.98 | 11.76 |
Net Cash Growth | -66.50% | 13.75% | -51.96% | -15.97% | -6.63% | -43.72% |
Net Cash Per Share | 0.18 | 0.46 | 0.80 | 3.27 | 5.41 | 5.75 |
Filing Date Shares Outstanding | 18.81 | 14.22 | 8.33 | 4.94 | 2.48 | 1.99 |
Total Common Shares Outstanding | 18.81 | 14.22 | 8.33 | 4.94 | 2.48 | 1.99 |
Working Capital | 3.45 | 2.7 | 4.39 | 9.67 | 10.98 | 11.49 |
Book Value Per Share | 0.20 | 0.22 | 0.57 | 2.00 | 4.50 | 5.87 |
Tangible Book Value | 3.84 | 3.1 | 4.74 | 9.88 | 11.16 | 11.7 |
Tangible Book Value Per Share | 0.20 | 0.22 | 0.57 | 2.00 | 4.50 | 5.87 |
Machinery | 0.1 | 0.09 | 0.1 | 0.12 | - | - |
Construction In Progress | 0.34 | 0.34 | 0.33 | 0.06 | - | - |